Drug Search Results
More Filters [+]

Ferrous fumarate

Alternative Names: ferrous fumarate, norlestrin fe 2.5/50, norlestrin fe 1/50, norquest fe, taysofy, loestrin fe 28 day, tarina 24 fe, lo loestrin fe, microgestin 24 fe, layolis fe, microgestin fe 1/20, microgestin fe 1.5/30, tarina fe 1/20 eq, junel fe 1.5/30, tilia fe, minastrin 24 fe, larin fe 1.5/30, larin fe 1/20, larin 24 fe, generess fe, hailey fe 1.5/30, junel fe 28 day, nexesta fe, hailey fe 1/20, aurovela 24 fe, junel fe 1/20, aurovela fe 1/20, aurovela fe, mibelas 24 fe, hailey 24 fe, merzee, charlotte 24fe, gemmily, junel fe 24, melodetta 24 fe, estrostep fe, taytulla
Latest Update: 2024-07-24
Latest Update Note: Clinical Trial Update

Product Description

The fumarate salt form of the mineral iron. Administration of ferrous fumarate results in elevation of serum iron concentration, which is then assimilated into hemoglobin, required for the transport of oxygen, or trapped in the reticuloendothelial cells for storage. This agent is used as a dietary supplement, and to prevent or treat iron deficiency related syndromes. (Sourced from: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrous-fumarate)

Mechanisms of Action: Hemoglobin Binder

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | Colombia | Cyprus | Czech | Dominican Republic | Ecuador | Egypt | Estonia | France | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Italy | Jordan | Latvia | Lebanon | Lithuania | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Pakistan | Peru | Philippines | Portugal | Romania | Serbia | Slovakia | Slovenia | South Africa | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Venezuela | Vietnam

Approved Indications: Pregnancy Outcomes | Pregnancy Outcomes

Known Adverse Events: Depressive Disorder | Abdominal Pain | Headache | Pain Unspecified | Injuries/wounds Unspecified | Candidiasis | Vaginitis | Weight Gain

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ferrous fumarate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events